A detailed history of Rtw Investments, LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 1,454,273 shares of ROIV stock, worth $17.1 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,454,273
Previous 1,454,273 -0.0%
Holding current value
$17.1 Million
Previous $15.3 Million 0.28%
% of portfolio
0.26%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$8.38 - $11.58 $824,960 - $1.14 Million
-98,444 Reduced 6.34%
1,454,273 $16.3 Million
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $5.19 Million - $7.49 Million
750,000 Added 93.43%
1,552,717 $11.5 Million
Q4 2021

Feb 14, 2022

BUY
$5.86 - $13.52 $4.7 Million - $10.9 Million
802,717 New
802,717 $8.09 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.28B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.